Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography

NCT02221141 is registered in ClinicalTrials.gov with Laurence Gabriel as lead sponsor.

NCT NCT02221141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02221141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography
Lead sponsor
Laurence Gabriel
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
April 30, 2021
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular hypertrophy